Login to Your Account



Precithera eyes lucrative orphan bone market with C$36M series A

By Marie Powers
News Editor

Thursday, July 27, 2017

Precithera Inc. completed a series A financing of C$36 million (US$29 million) from an investor syndicate that included Sanderling Ventures, Arix Bioscience Ltd., Fonds de solidarité FTQ, CTI Life Sciences and Emerillon Capital.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription